Galectin−1 suppresses FBP1 to activate RAS/ERK signaling and facilitate intrahepatic cholangiocarcinoma progression
Current Molecular Pharmacology · 2026 · 19 (1) · 181-194
DOI: 10.1016/j.cmp.2026.07.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Molecular Pharmacology, 2026. Verfasst von Yu Tian und 12 weiteren Autor:innen. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Tian, Y., Zhou, H., Lin, J., Zhang, K., He, R., Duan, H., Jiang, J., Jiang, Y., Zheng, M., Itzstein, M. V., Li, H., Li, Z., & Yu, X. (2026). Galectin−1 suppresses FBP1 to activate RAS/ERK signaling and facilitate intrahepatic cholangiocarcinoma progression. Current Molecular Pharmacology, 19(1), 181-194. https://doi.org/10.1016/j.cmp.2026.07.002
Vancouver
Tian Y, Zhou H, Lin J, Zhang K, He R, Duan H, et al. Galectin−1 suppresses FBP1 to activate RAS/ERK signaling and facilitate intrahepatic cholangiocarcinoma progression. Current Molecular Pharmacology. 2026;19(1):181-194. doi:10.1016/j.cmp.2026.07.002
BibTeX
@article{Tian2026,
author = {Tian, Yu and Zhou, Huiqin and Lin, Junyu and Zhang, Ke and He, Ruiqi and Duan, Huahong and Jiang, Jiayang and Jiang, Yiqun and Zheng, Mao and Itzstein, Mark von and Li, Hao and Li, Zhenfa and Yu, Xing},
title = {Galectin−1 suppresses FBP1 to activate RAS/ERK signaling and facilitate intrahepatic cholangiocarcinoma progression},
journal = {Current Molecular Pharmacology},
year = {2026},
volume = {19},
number = {1},
pages = {181--194},
doi = {10.1016/j.cmp.2026.07.002}
}
EUVIMED